Please assess the completion status of the following clinical trial:

Trial Title: The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal women with a T-score ≤ -1.5 SD and at least one osteoporosis related vertebral fracture. Chronic back pain.~Exclusion Criteria:~* Previous/current treatment and medical history.

- Gender: FEMALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PTH (1-84) (Type: ACTIVE_COMPARATOR): PTH (1-84) + placebo alendronate
- Alendronate (Type: ACTIVE_COMPARATOR): PTH (1-84) placebo + alendronate

Based on this trial design, predict the completion outcome and termination type (if applicable).